| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.71B | $4.09B | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $2.43B | $2.07B | $0 |
| Gross Margin % | 51.5% | 50.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.47B | $1.10B | $1.06B |
| Operating Margin % | 31.1% | 26.8% | — |
| Net Income (GAAP) | $1.10B | $764.9M | $761.4M |
| EBITDA (Normalized) | $1.52B | $1.15B | $1.06B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.75B | $1.10B | $1.08B |
| Capital Expenditures (CapEx) | $71.0M | $60.9M | $0 |
| Free Cash Flow (FCF) | $1.68B | $1.04B | $1.08B |
| FCF Margin % | 35.7% | 25.4% | — |
| Return on Invested Capital (ROIC %) | 26.6% | 18.1% | 7.2% |
| Cash & Short-Term Equivalents | $2.22B | $920.3M | — |
| Total Debt (Short + Long Term) | $1.44B | $1.44B | $4.52B |
| Total Stockholders' Equity | $5.14B | $4.28B | $9.28B |